These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 30280763)
21. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma. Tian ZZ; Guo XJ; Zhao YM; Fang Y Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857 [TBL] [Abstract][Full Text] [Related]
22. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression. Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116 [TBL] [Abstract][Full Text] [Related]
23. Increased PTOV1 expression is related to poor prognosis in epithelial ovarian cancer. Guo F; Feng L; Hu JL; Wang ML; Luo P; Zhong XM; Deng AM Tumour Biol; 2015 Jan; 36(1):453-8. PubMed ID: 25270739 [TBL] [Abstract][Full Text] [Related]
24. lncRNAs as Novel Indicators of Patients' Prognosis in Stage I Epithelial Ovarian Cancer: A Retrospective and Multicentric Study. Martini P; Paracchini L; Caratti G; Mello-Grand M; Fruscio R; Beltrame L; Calura E; Sales G; Ravaggi A; Bignotti E; Odicino FE; Sartori E; Perego P; Katsaros D; Craparotta I; Chiorino G; Cagnin S; Mannarino L; Ceppi L; Mangioni C; Ghimenti C; D'Incalci M; Marchini S; Romualdi C Clin Cancer Res; 2017 May; 23(9):2356-2366. PubMed ID: 27827314 [No Abstract] [Full Text] [Related]
25. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival. Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495 [TBL] [Abstract][Full Text] [Related]
26. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer. Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239 [TBL] [Abstract][Full Text] [Related]
27. LINC01116 promotes the progression of epithelial ovarian cancer via regulating cell apoptosis. Fang YN; Huang ZL; Li H; Tan WB; Zhang QG; Wang L; Wu JL Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5127-5133. PubMed ID: 30178832 [TBL] [Abstract][Full Text] [Related]
28. LncRNA SNHG20 predicts a poor prognosis and promotes cell progression in epithelial ovarian cancer. Wang D; Dai J; Hou S; Qian Y Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30846486 [TBL] [Abstract][Full Text] [Related]
29. PRSS3 expression is associated with tumor progression and poor prognosis in epithelial ovarian cancer. Ma R; Ye X; Cheng H; Ma Y; Cui H; Chang X Gynecol Oncol; 2015 Jun; 137(3):546-52. PubMed ID: 25735255 [TBL] [Abstract][Full Text] [Related]
30. Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer. Wan WN; Zhang YQ; Wang XM; Liu YJ; Zhang YX; Que YH; Zhao WJ; Li P Diagn Pathol; 2014 Sep; 9():178. PubMed ID: 25257702 [TBL] [Abstract][Full Text] [Related]
31. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer. Lv Q; Sun H; Cao C; Gao B; Qi Y Tumour Biol; 2016 Feb; 37(2):2721-7. PubMed ID: 26408177 [TBL] [Abstract][Full Text] [Related]
32. Overexpression of long noncoding RNA PTPRG-AS1 is associated with poor prognosis in epithelial ovarian cancer. Ren XY; Yang WB; Tian Y Rev Assoc Med Bras (1992); 2020 Jul; 66(7):948-953. PubMed ID: 32844927 [TBL] [Abstract][Full Text] [Related]
33. Expression of Gab1 Is Associated with Poor Prognosis of Patients with Epithelial Ovarian Cancer. Hu L; Liu R Tohoku J Exp Med; 2016 Jul; 239(3):177-84. PubMed ID: 27302321 [TBL] [Abstract][Full Text] [Related]
34. Serum lncRNA LOXL1-AS1 is a diagnostic and prognostic marker for epithelial ovarian cancer. Liu CN; Zhang HY J Gene Med; 2020 Oct; 22(10):e3233. PubMed ID: 32449981 [TBL] [Abstract][Full Text] [Related]
35. Downregulated Long Noncoding RNA DGCR5 Acts as a New Promising Biomarker for the Diagnosis and Prognosis of Ovarian Cancer. Chen H; Tian X; Luan Y; Lu H Technol Cancer Res Treat; 2019; 18():1533033819896809. PubMed ID: 31868103 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma. Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-184 acts as a potential diagnostic and prognostic marker in epithelial ovarian cancer and regulates cell proliferation, apoptosis and inflammation. Qin CZ; Lou XY; Lv QL; Cheng L; Wu NY; Hu L; Zhou HH Pharmazie; 2015 Oct; 70(10):668-73. PubMed ID: 26601424 [TBL] [Abstract][Full Text] [Related]
38. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer. Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366 [TBL] [Abstract][Full Text] [Related]
39. Significance of MNK1 in prognostic prediction and chemotherapy development of epithelial ovarian cancer. Hou S; Du P; Wang P; Wang C; Liu P; Liu H Clin Transl Oncol; 2017 Sep; 19(9):1107-1116. PubMed ID: 28332091 [TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and prognostic significance of caveolin-1 and ATG4C expression in the epithelial ovarian cancer. Zeng Y; Chen M; Ganesh S; Hu S; Chen H PLoS One; 2020; 15(5):e0232235. PubMed ID: 32401768 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]